{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:36:27Z","timestamp":1790958987189,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Construction Project of Henan Province","award":["LHGJ20210594"],"award-info":[{"award-number":["LHGJ20210594"]}]},{"name":"Joint Construction Project of Henan Province","award":["LHGJ20210594"],"award-info":[{"award-number":["LHGJ20210594"]}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["32072899"],"award-info":[{"award-number":["32072899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["32072899"],"award-info":[{"award-number":["32072899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henan Science and Technology Development Plan","award":["212102310741"],"award-info":[{"award-number":["212102310741"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10615-0","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:08:01Z","timestamp":1739473681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of molecular resistance and associated risk factors in tuberculosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhenzhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"1","key":"10615_CR1","doi-asserted-by":"publisher","first-page":"2302837","DOI":"10.1080\/22221751.2024.2302837","volume":"13","author":"M Li","year":"2024","unstructured":"Li M, Zhang Y, Wu Z, Jiang Y, Sun R, Yang J, et al. Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study. Emerg Microbes Infect. 2024;13(1):2302837.","journal-title":"Emerg Microbes Infect"},{"issue":"21","key":"10615_CR2","first-page":"4","volume":"42","author":"L Youfeng","year":"2021","unstructured":"Youfeng L. Interaction and rational use of antituberculosis drugs. Shanghai Pharmaceut. 2021;42(21):4.","journal-title":"Shanghai Pharmaceut"},{"issue":"7","key":"10615_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(24)00069-0","volume":"24","author":"X Wei","year":"2024","unstructured":"Wei X, Zhang W. The hidden threat of subclinical tuberculosis. Lancet Infect Dis. 2024;24(7):669\u201370.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10615_CR4","doi-asserted-by":"publisher","first-page":"e20230859","DOI":"10.1084\/jem.20230859","volume":"220","author":"BR Bloom","year":"2023","unstructured":"Bloom BR. A half-century of research on tuberculosis: Successes and challenges. J Exp Med. 2023;220(9):e20230859.","journal-title":"J Exp Med"},{"key":"10615_CR5","doi-asserted-by":"crossref","unstructured":"WHO: Global tuberculosis report. 2023(978\u201392\u20134\u2013008385\u20131).","DOI":"10.1016\/S2666-5247(22)00359-7"},{"issue":"16","key":"10615_CR6","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJMp2118145","volume":"386","author":"P Madhukar","year":"2022","unstructured":"Madhukar P, Tereza K, Soumya S. Covid-19\u2019s Devastating Effect on Tuberculosis Care - A Path to Recovery. N Engl J Med. 2022;386(16):1490\u20133.","journal-title":"N Engl J Med"},{"issue":"6","key":"10615_CR7","first-page":"857","volume":"45","author":"XY Wang","year":"2024","unstructured":"Wang XY, Jiang ML, Pang YJ, Sun DJY, Yu CQ, Wang L, et al. Current status of tuberculosis burden in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2024;45(6):857\u201364.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10615_CR8","doi-asserted-by":"crossref","unstructured":"Kathryn A E, Madeleine D, Vanisha M-G, Michael A D, Zachary A A, Abhijna K R, et al. Compensatory evolution in NusG improves fitness of drug-resistant M. tuberculosis. Nature. 2024;628(8006):186\u201394.","DOI":"10.1038\/s41586-024-07206-5"},{"key":"10615_CR9","doi-asserted-by":"crossref","unstructured":"Christoph L, Keertan D, Dumitru C, Anna Maria M, Zarir U, C Robert Jr H. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953\u201366.","DOI":"10.1016\/S0140-6736(19)31882-3"},{"key":"10615_CR10","unstructured":"Organization WH. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. Available from:  https:\/\/www.who.int\/publications\/i\/item\/9789241549639."},{"key":"10615_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijid.2023.03.013","volume":"130","author":"E Vanino","year":"2023","unstructured":"Vanino E, Granozzi B, Akkerman OW, Munoz-Torrico M, Palmieri F, Seaworth B, et al. Update of drug-resistant tuberculosis treatment guidelines: A turning point. Int J Infect Dis. 2023;130:3.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10615_CR12","first-page":"e01663","volume":"65","author":"M Willby","year":"2023","unstructured":"Willby M, Chopra P, Lemmer D, Klein K, Dalton T, Engelthaler D, et al. Molecular Evaluation of Fluoroquinolone Resistance in Serial Mycobacterium tuberculosis Isolates from Individuals Diagnosed with Multidrug-Resistant Tuberculosis. Antimicrobial Agents Chemotherapy. 2023;65(1):e01663-20.","journal-title":"Antimicrobial Agents Chemotherapy"},{"issue":"3","key":"10615_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00409-21","volume":"9","author":"H Xia","year":"2021","unstructured":"Xia H, Zheng Y, Liu D, Wang S, He W, Zhao B, et al. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013. Microbiol Spectr. 2021;9(3): e0040921.","journal-title":"Microbiol Spectr"},{"key":"10615_CR14","first-page":"033","volume":"005","author":"X Peng","year":"2022","unstructured":"Peng X, Zhu H. Analysis of epidemic characteristics of pulmonary tuberculosis in Xinxian County, Henan Province from 2006 to 2020. Henan J Prev Med. 2022;005:033.","journal-title":"Henan J Prev Med"},{"issue":"1","key":"10615_CR15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s12879-024-09395-w","volume":"24","author":"W Zhenzhen","year":"2024","unstructured":"Zhenzhen W, Tengfei G, Liyang X, Jinwei L, Yi H, Junrong J, et al. Regional differences of Mycobacterium tuberculosis complex infection and multidrug resistance epidemic in Luoyang. BMC Infect Dis. 2024;24(1):578.","journal-title":"BMC Infect Dis"},{"key":"10615_CR16","unstructured":"Zhao Yanlin, Chen Mingting.\u00a0Technical Guide for Tuberculosis Prevention and Control in China. People's Medical Publishing House, 2021."},{"issue":"5","key":"10615_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5588\/ijtld.14.0798","volume":"19","author":"J Ho","year":"2015","unstructured":"Ho J, Marks GB, Fox GJ. The impact of sputum quality on tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis. 2015;19(5):537\u201344.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10615_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S2213-2600(22)00092-3","volume":"10","author":"K Dheda","year":"2022","unstructured":"Dheda K, Perumal T, Moltrie H, Perumal R, Esmail A, Scott AJ, et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022;10(6):603\u201322.","journal-title":"Lancet Respir Med"},{"key":"10615_CR19","doi-asserted-by":"crossref","unstructured":"Wang Z, Guo T, Jiang T, Zhao Z, Zu X, li L, Zhang Q, et al. Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis. BMC Infectious Diseases. 2022;22(1):812.","DOI":"10.1186\/s12879-022-07792-7"},{"issue":"12","key":"10615_CR20","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","volume":"68","author":"K L\u00f6nnroth","year":"2009","unstructured":"L\u00f6nnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240\u20136.","journal-title":"Soc Sci Med"},{"issue":"1","key":"10615_CR21","doi-asserted-by":"publisher","first-page":"22361","DOI":"10.1038\/s41598-023-47094-9","volume":"13","author":"TY Akalu","year":"2023","unstructured":"Akalu TY, Clements ACA, Wolde HF, Alene KA. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis. Sci Rep. 2023;13(1):22361.","journal-title":"Sci Rep"},{"issue":"27","key":"10615_CR22","first-page":"3","volume":"56","author":"N Hongye","year":"2018","unstructured":"Hongye N, Xiangao J, Jichan S, Guiqing H, Zhengxing W. Distribution of pathogens and drug resistance of pulmonary infection in elderly patients with pulmonary tuberculosis. China Modern Doctor. 2018;56(27):3.","journal-title":"China Modern Doctor"},{"issue":"3","key":"10615_CR23","first-page":"3","volume":"18","author":"W Weihua","year":"2005","unstructured":"Weihua W, Qionghong D, Zuxun L, Lanying L, Baodong Y, Qingzhi Z. Factors Influencing the Quality of life of the Patients with Multidrug Resistant Pulmonory Tuberculosis. Med Soc. 2005;18(3):3.","journal-title":"Med Soc"},{"issue":"1","key":"10615_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2352-4642(19)30337-2","volume":"4","author":"KJ Snow","year":"2020","unstructured":"Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020;4(1):68\u201379.","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10615_CR25","doi-asserted-by":"publisher","first-page":"e2023063910","DOI":"10.1542\/peds.2023-063910","volume":"153","author":"W Shang","year":"2024","unstructured":"Shang W, Cao G, Jing W, Liu J, Liang W, Liu M. Global Burden of Tuberculosis in Adolescents and Young Adults: 1990\u20132019. Pediatrics. 2024;153(4):e2023063910.","journal-title":"Pediatrics"},{"issue":"3","key":"10615_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/tropicalmed6030148","volume":"6","author":"KM Laycock","year":"2021","unstructured":"Laycock KM, Enane LA, Steenhoff AP. Tuberculosis in Adolescents and Young Adults Emerging Data on TB Transmission and Prevention among Vulnerable Young People. Trop Med Infect Dis. 2021;6(3):148.","journal-title":"Trop Med Infect Dis"},{"issue":"12","key":"10615_CR27","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3390\/pathogens11121512","volume":"11","author":"TY Boris","year":"2022","unstructured":"Boris TY, Boris Kevin T, Stephen MG, Maryline B. Tuberculosis Infection in Children and Adolescents. Pathogens. 2022;11(12):1512.","journal-title":"Pathogens"},{"key":"10615_CR28","first-page":"4","volume":"10","author":"Z Bao-ping","year":"2021","unstructured":"Bao-ping Z, Qian W, Xue J. Factors influencing tuberculosis in adolescents. Pract Prev Med. 2021;10:4.","journal-title":"Pract Prev Med"},{"key":"10615_CR29","unstructured":"Survey TGGotFNTE, Survey TOotFNTE. The fifth national tuberculosis epidemiological survey in 2010 Chinese. J Antituberculosis. 2012;34(8):23."},{"key":"10615_CR30","unstructured":"Organization WH. Anti-tuberculosis drug resistance in the world: fourth global report. World Health Organization 2008. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241563611."},{"key":"10615_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12879-015-1202-7","volume":"15","author":"F Mekonnen","year":"2015","unstructured":"Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho. Northwest Ethiopia BMC Infect Dis. 2015;15:461.","journal-title":"Northwest Ethiopia BMC Infect Dis"},{"issue":"10202","key":"10615_CR32","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","volume":"394","author":"C Lange","year":"2019","unstructured":"Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR, et al. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953\u201366.","journal-title":"Lancet"},{"issue":"6","key":"10615_CR33","first-page":"7","volume":"45","author":"L Yang","year":"2021","unstructured":"Yang L, Wenhong Z. Updates of anti-tuberculosis drugs for the treatment of multidrug resistant tuberculosis. Progress Pharmaceut Sci. 2021;45(6):7.","journal-title":"Progress Pharmaceut Sci"},{"key":"10615_CR34","unstructured":"Organization W H. Management of MDR-TB: a field guide. 2009. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK310797\/."},{"key":"10615_CR35","doi-asserted-by":"crossref","unstructured":"Hu Y, CY, Feng X, Yu F, Li H, Shang Y, et al. Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates. J Mol Diagn. 2023;25(6):9.","DOI":"10.1016\/j.jmoldx.2023.02.003"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10615-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10615-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10615-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:08:12Z","timestamp":1739473692000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10615-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10615"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10615-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of The First Affiliated Hospital, and College of Clinical Medical of Henan University of Science and Technology (Approval Registration Number\u20142022\/03\/B070). The need for informed consent was waived by this Ethics Committee considering the retrospective nature of the study and the anonymous clinical data used for analysis. The privacy and confidentiality of participants were maintained throughout the study. All research procedures complied with the ethical standards of the First Affiliated Hospital of Henan University of Science and Technology and the Declaration of Helsinki from 1975.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}